We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

44 hedge funds and large institutions have $212M invested in Cogent Biosciences in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

57% more funds holding

Funds holding: 28 → 44 (+16)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

14% more capital invested

Capital invested by funds: $186M → $212M (+$26.7M)

9.35% less ownership

Funds ownership: 22.23% → 12.88% (-9.3%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
44
Holders Change
+16
Holders Change %
+57.14%
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
28
Increased
5
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NLVP
New Leaf Venture Partners
New York
+$15M
2
CI
Cowen Inc
New York
+$6.98M
3
BlackRock
BlackRock
New York
+$5.36M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.87M
5
Bank of America
Bank of America
North Carolina
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$3.16M
2
Victory Capital Management
Victory Capital Management
Texas
-$2.78M
3
Morgan Stanley
Morgan Stanley
New York
-$2.26M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.09M
5
MIM
Monashee Investment Management
Massachusetts
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$120K +$101K +2,098 New
CSS
27
Cubist Systematic Strategies
Connecticut
$90K +$75.4K +1,568 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$78K +$65.2K +1,356 New
UBS Group
29
UBS Group
Switzerland
$48K +$39.9K +830 New
AIG
30
American International Group
New York
$33K +$27.7K +577 New
SO
31
STRS Ohio
Ohio
$14K +$12K +250 New
TDC
32
Thompson Davis & Co
Virginia
$12K +$10.4K +217 New
Legal & General Group
33
Legal & General Group
United Kingdom
$11K +$8.99K +187 New
JP Morgan Chase
34
JP Morgan Chase
New York
$10K +$8.65K +180 New
CCA
35
Catalyst Capital Advisors
New York
$9K +$2.16K +45 +43%
CI
36
Cowen Inc
New York
$8.34K +$6.98M +145,314 New
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$7K +$6.01K +125 New
Citigroup
38
Citigroup
New York
$7K +$6.11K +127 New
Barclays
39
Barclays
United Kingdom
$4K +$3.12K +65 New
AIP
40
Ameritas Investment Partners
Nebraska
$4K +$3.32K +69 New
TRCT
41
Tower Research Capital (TRC)
New York
$4K +$3.41K +71 New
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$1.67K +$1.39K +29 New
PIA
43
Piedmont Investment Advisors
North Carolina
$1K +$769 +16 New
Victory Capital Management
44
Victory Capital Management
Texas
– -$2.78M -62,500 Closed
MIM
45
Monashee Investment Management
Massachusetts
– -$1.94M -43,750 Closed
HI
46
HBK Investments
Texas
– -$1.78M -40,000 Closed
Norges Bank
47
Norges Bank
Norway
– -$1.11M -25,000 Closed
Millennium Management
48
Millennium Management
New York
– -$982K -22,101 Closed
SSA
49
Schonfeld Strategic Advisors
New York
– -$811K -18,250 Closed
HCMT
50
Highland Capital Management (Texas)
Texas
– -$770K -17,336 Closed
1
2
3

COGT Hedge Fund Activity: Q2 2018 in Review

44 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q2 2018, worth a combined $212M — up 14% from $186M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new COGT positions and 11 closed out — a net gain of 17 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was New Leaf Venture Partners, adding an estimated $15M. The largest seller was Sabby Management, cutting an estimated $3.16M.

  • 44 institutional investors held Cogent Biosciences (COGT) as of Q2 2018, up from 28 in Q1 2018.
  • Funds reported $212M of Cogent Biosciences stock for Q2 2018, up 14% quarter-over-quarter.
  • 28 funds opened new Cogent Biosciences positions in Q2 2018 and 11 closed out, a net change of +17 holders.
  • The largest Cogent Biosciences buyer in Q2 2018 was New Leaf Venture Partners, an estimated $15M added.
  • The largest Cogent Biosciences seller in Q2 2018 was Sabby Management, an estimated $3.16M sold.

Based on aggregated 13F filings for Q2 2018.